Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Estonian ICUs join forces to uncover hidden gut crisis

NCT ID NCT07610356

Knowledge-focused Sponsor: University of Tartu Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is watching 150 ICU patients in Estonia who doctors suspect have acute mesenteric ischemia, a rare but deadly gut condition. Researchers will track medical records, lab results, and CT scans to find clues that predict severe bowel damage. No new treatments are being tested; the goal is to learn which warning signs matter most.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could help doctors identify which ICU patients are at highest risk of severe bowel damage from mesenteric ischemia, potentially leading to earlier diagnosis and better outcomes.
What could go wrong
This is an observational study, not a treatment trial, so it will not directly test any new therapy. The findings may not apply to all hospitals or patient groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 150 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2022

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

All adult patients who develop suspicion of acute mesenteric ischemia during their ICU stay will be included in the study. The study will take place in the ICUs of the two largest hospitals in Estonia: Tartu University Hospital and North Estonian Medical Centre.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria \- Adult ICU patients in whom clinical suspicion of acute mesenteric ischemia is raised during their ICU stay. Exclusion criteria * Patients who develop acute mesenteric ischemia outside of the intensive care unit, * Confirmed strangulating bowel obstruction, * Individuals younger than 18 years, * Chronic mesenteric ischemia without an acute event.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute mesenteric ischemia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

acute intestinal ischemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Acute mesenteric ischemia Non-occlusive mesenteric ischaemia (NOMI)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • North Estonia Medical Centre

    RECRUITING

    Tallinn, Tallinn, 13419, Estonia

  • Tartu University Hospital

    RECRUITING

    Tartu, Tartu, 50406, Estonia

More trials for these conditions

Other studies related to the condition(s) this trial covers.